MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Rating) is one of 1,001 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its rivals? We will compare MoonLake Immunotherapeutics to related businesses based on the strength of its analyst recommendations, dividends, institutional ownership, earnings, profitability, valuation and risk. Insider & Institutional Ownership 76.1% of […]